In 2020, the growth of China’s API export was stimulated by the epidemic, which boosted the global demand for ANTI-epidemic APIS, and also affected the production of other major API producers such as India and the European Union. As a result, the transfer orders of China’s API from the international market increased. Specifically, the export quantity of China’s API increased by 7.5% year on year, reaching 10.88 million tons. From specific export category, anti-infection, vitamins, hormones, antipyretic analgesic, part of antibiotic resistance to disease related API category of export amount is mostly realized the different levels of growth, some specific varieties is growing rapidly, such as dexamethasone exports rose 55% year-on-year, lamivudine, vitamin C, vitamin E and other exports more than 30% year-on-year growth, Paracetamol, annannin and other exports year-on-year growth of more than 20%.